Privia Health Group (NASDAQ:PRVA – Get Free Report) is projected to announce its earnings results before the market opens on Thursday, February 27th. Analysts expect the company to announce earnings of $0.05 per share and revenue of $422.01 million for the quarter. Investors interested in participating in the company’s conference call can do so using this link.
Privia Health Group Price Performance
PRVA opened at $24.51 on Tuesday. Privia Health Group has a 1 year low of $15.92 and a 1 year high of $25.67. The firm has a market capitalization of $2.94 billion, a PE ratio of 245.12, a price-to-earnings-growth ratio of 3.47 and a beta of 0.87. The business’s 50-day moving average is $22.05 and its two-hundred day moving average is $20.46.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently weighed in on the company. Barclays boosted their price target on Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research note on Friday, November 8th. JMP Securities restated a “market outperform” rating and set a $26.00 price target on shares of Privia Health Group in a research note on Friday, February 14th. Stephens restated an “overweight” rating and set a $26.00 price target on shares of Privia Health Group in a research note on Thursday, January 2nd. Needham & Company LLC assumed coverage on Privia Health Group in a research note on Friday, January 10th. They set a “buy” rating and a $25.00 price target on the stock. Finally, JPMorgan Chase & Co. boosted their price target on Privia Health Group from $27.00 to $28.00 and gave the stock an “overweight” rating in a research note on Friday, November 29th. One analyst has rated the stock with a hold rating, fifteen have assigned a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, Privia Health Group presently has an average rating of “Buy” and a consensus target price of $25.18.
Privia Health Group Company Profile
Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.
Featured Stories
- Five stocks we like better than Privia Health Group
- What Are Dividend Contenders? Investing in Dividend Contenders
- Finding Hidden Gems: Unconventional Penny Stock Investing
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Price Targets on NVIDIA Rise in Front of Earnings
- How to Invest in Biotech Stocks
- Archer Aviation Stock Skids: Mistaking Progress for Bad News?
Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.com's FREE daily email newsletter.